Aktive Positionen von Sylvain Guénette
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | - | - |
| Finanzdirektor/CFO | - | - |
Karriereverlauf von Sylvain Guénette
Ehemalige bekannte Positionen von Sylvain Guénette
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Comptroller/Controller/Auditor | 23.03.2011 | - |
| Finanzdirektor/CFO | 23.03.2011 | - |
Statistik
International
| Kanada | 3 |
Operativ
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Börse
- Insiders
- Sylvain Guénette
- Erfahrung
